BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 4404402)

  • 1. Cardioselective beta-adrenergic blockade.
    Fitzgerald JD
    Proc R Soc Med; 1972 Sep; 65(9):761-4. PubMed ID: 4404402
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac toxicity of -lytic drugs.
    Roba J
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:120-. PubMed ID: 4403294
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of beta-blocking agents.
    Goldstein RE
    Circulation; 1973 Mar; 47(3):443-5. PubMed ID: 4144218
    [No Abstract]   [Full Text] [Related]  

  • 4. [Basis for the use of beta-receptor blockaders in the practice].
    Blankart R
    Schweiz Rundsch Med Prax; 1973 Aug; 62(32):975-8. PubMed ID: 4147247
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological studies of two new cardioselective adrenergic beta-receptor antagonists.
    Ablad B; Carlsson E; Ek L
    Life Sci I; 1973 Feb; 12(3):107-19. PubMed ID: 4144510
    [No Abstract]   [Full Text] [Related]  

  • 6. Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents.
    Hellenbrecht D; Lemmer B; Wiethold G; Grobecker H
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(2):211-26. PubMed ID: 4145013
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of propranolol, oxprenolol, and practolol on denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br Heart J; 1971 Jul; 33(4):614-5. PubMed ID: 4397631
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison of the effects of propranolol, practolol, oxyprenolol and L.B. 46 on myocardial contractility].
    Adamska-Dyniewska H
    Wiad Lek; 1973 Apr; 26(7):603-8. PubMed ID: 4144788
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiospecificity of -receptor blockade. A comparison of the relative potencies on cardiac and peripheral vascular -adrenoceptors of propranolol, of practolol and its ortho-substituted isomer, and of oxprenolol and its para-substituted isomer.
    Williams EM; Bagwell EE; Singh BN
    Cardiovasc Res; 1973 Mar; 7(2):226-40. PubMed ID: 4144352
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of beta-adrenergic blocking agents on the spontaneous motility of mice.
    Fabian HE; Izquierdo JA
    Arzneimittelforschung; 1972 Aug; 22(8):1375-6. PubMed ID: 4404659
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological studies on 1-(7-indenyloxy)-3-isopropylaminopropan-2-Ol hydrochloride (YB-2), a new -adrenergic blocking agent.
    Tachikawa S; Takenaka T
    Arch Int Pharmacodyn Ther; 1973 Mar; 202(1):79-92. PubMed ID: 4144371
    [No Abstract]   [Full Text] [Related]  

  • 12. Protection against isoprenaline induced myocardial necroses by beta-adrenergic blocking agents.
    Kulig A; Kostka-Trabka E; Gryglewski R
    Pol J Pharmacol Pharm; 1973; 25(1):85-90. PubMed ID: 4149575
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of butoxamine, N-isopropylmethoxamine and salbutamol (AH-3365) on melanophore beta-adrenergic receptors.
    Goldman JM; Hadley ME
    J Pharm Pharmacol; 1969 Dec; 21(12):854-5. PubMed ID: 4391059
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in effort tolerance in patients with coronary arterial disease following administration of 4 beta-adrenolytic agents (propranolol, visken, oxyprenolol and practolol)].
    Adamska-Dyniewska H
    Wiad Lek; 1973 Jul; 26(13):1201-5. PubMed ID: 4147032
    [No Abstract]   [Full Text] [Related]  

  • 15. The pharmacology of practolol, a cardioselective beta adrenergic blocking drug.
    Fitzgerald JD
    Acta Cardiol; 1972; Suppl 16():1-18. PubMed ID: 4405742
    [No Abstract]   [Full Text] [Related]  

  • 16. [Properties of beta-adrenergic receptors of heart and lung--studies with "cardioselective" beta-receptor blocking substances].
    Krawietz W; Weinsteiger M; Pruchniewski M; Erdmann E
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():414-5. PubMed ID: 26149
    [No Abstract]   [Full Text] [Related]  

  • 17. [Specific differences between the adrenergic beta receptors of the heart and coronary vessels].
    Bayer BL; Mentz P; Förster W
    Arch Int Pharmacodyn Ther; 1972 Dec; 200(2):341-7. PubMed ID: 4405155
    [No Abstract]   [Full Text] [Related]  

  • 18. Potentiation of bronchomotor responses by beta adrenergic antagonists.
    Diamond L
    J Pharmacol Exp Ther; 1972 Jun; 181(3):434-45. PubMed ID: 4402373
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective beta adrenergic receptor blockade in the rat.
    Wasserman MA; Levy B
    J Pharmacol Exp Ther; 1972 Aug; 182(2):256-63. PubMed ID: 4403093
    [No Abstract]   [Full Text] [Related]  

  • 20. Selectivity in new -adrenergic blocking agents. (3-Amino-2-hydroxypropoxy)benzamides.
    Shtacher G; Erez M; Cohen S
    J Med Chem; 1973 May; 16(5):516-9. PubMed ID: 4146253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.